NCT07224061

Brief Summary

The overall goal of this research study is to evaluate a multi-level program called PRAGMATIC-S to improve the delivery of guideline-based asthma care through a unique partnership between clinical practices and schools. PRAGMATIC-S represents a novel approach that addresses multiple barriers to adherence by bridging primary care and schools, ensuring delivery of guideline-based asthma care to urban children across these settings thereby improving adherence to therapy and clinical outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
420

participants targeted

Target at P75+ for not_applicable

Timeline
87mo left

Started Feb 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Feb 2026Jun 2033

First Submitted

Initial submission to the registry

October 30, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 3, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

February 12, 2026

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2031

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2033

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

5.4 years

First QC Date

October 30, 2025

Last Update Submit

April 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Asthma Control - continuous

    Asthma control will be measured using the Childhood Asthma Control Test (cACT), 7-item scale which determines a score based on the sum of the response codes. The child answers the first 4 questions on a 4-point scale ranging from 0-3 and the caregiver provides responses for the final 3 items using a reverse-coded scale ranging from 0 ("Everyday") to 5 ("Not at all"), yielding an overall possible scoring range of 0-27, with higher scores indicating better asthma control. Asthma control will be analyzed as a continuous variable.

    Baseline, 4 months, 8 months, and 12 months

Secondary Outcomes (3)

  • Pediatric Asthma Caregiver's Quality of Life

    Baseline, 4 months, 8 months, and 12 months

  • Percent of participants with 1 or more guideline-based corrective actions taken

    Up to 24 months (following intervention)

  • Asthma Control - dichotomous

    Baseline, 4 months, 8 months, and 12 months

Other Outcomes (2)

  • Health care utilization - number of Emergency Department (ED) visits for asthma

    every 4 months up to 12 months

  • Health care utilization - number of hospitalizations for asthma

    every 4 months up to 12 months

Study Arms (2)

PRAGMATIC-S

EXPERIMENTAL

Primary Care Providers (PCPs) will use guideline-based prompts within EHR; PCPs and caregivers will complete medication administration forms electronically with forms routed directly to schools to receive asthma medications at the school, and asthma outreach workers will serve as liaison between families, PCPs, schools and provide care coordination and support.

Behavioral: PRAGMATIC-S

Enhanced Usual Care

NO INTERVENTION

Standard of care EHR clinician prompts for guideline-based asthma care

Interventions

PRAGMATIC-SBEHAVIORAL

Intervention combines EHR-based guideline prompts, electronic MAF submission, school-based directly observed therapy (DOT), and Asthma Outreach Workers (AOWs) providing care coordination, adherence support, and communication between families, schools, and providers.

PRAGMATIC-S

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Physician-diagnosed asthma documented in EHR
  • Persistent asthma, not on controller medications or uncontrolled asthma despite therapy (with any one of the following per age-specific guidelines: in past month, \>2 days/week with symptoms, \>2 days/week using rescue medication, \>2 days/month with nighttime symptoms, or \>2 episodes/year that required systemic corticosteroids
  • Age 4 to 12 years, inclusive, attending pre-kindergarten through 7th grade in public / charter / private schools in New York City (the Bronx primarily) and also schools in lower Hudson Valley (Eastchester, Westchester, Rockland, Yonkers)
  • Caregiver is able to speak and understand either English or Spanish. Participants unable to read will be eligible as all surveys will be administered verbally by research personnel
  • Consent from primary caregiver and assent from child (age ≥7 years). If there are eligible siblings with exact same asthma severity/control screening results, one child will be randomly selected to participate, otherwise the sibling with worse asthma symptoms will be selected.
  • Presence of a phone to conduct surveys and smartphone, iPad or computer to electronically complete and e-sign MAF

You may not qualify if:

  • Family plans to leave school or city within 6 months
  • Significant medical conditions (e.g., congenital heart disease, cystic fibrosis, or other chronic lung disease)
  • Children in foster care or other situations in which consent cannot be obtained from a legal guardian
  • Participation in concurrent asthma intervention study
  • Severe developmental delay (e.g., severe autism) precluding completion of asthma control questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital at Montefiore, Albert Einstein College of Medicine

The Bronx, New York, 10467, United States

RECRUITING

Related Publications (58)

  • Walters S, Wilson L, Konty K, Day S, Agerton T, Olson C. Disparities among children with asthma in New York City. Epi Data Brief (126); September 2021.

    BACKGROUND
  • Black LI, Benson V. Tables of Summary Health Statistics for U.S. Children: 2018 National Health Interview Survey.

    BACKGROUND
  • Reznik M, Jaramillo Y, Wylie-Rosett J. Demonstrating and assessing metered-dose inhaler-spacer technique: pediatric care providers' self-reported practices and perceived barriers. Clin Pediatr (Phila). 2014 Mar;53(3):270-6. doi: 10.1177/0009922813512521. Epub 2013 Dec 12.

    PMID: 24336438BACKGROUND
  • Frey SM, Fagnano M, Halterman JS. Caregiver education to promote appropriate use of preventive asthma medications: what is happening in primary care? J Asthma. 2016;53(2):213-9. doi: 10.3109/02770903.2015.1075549. Epub 2015 Aug 18.

    PMID: 26288255BACKGROUND
  • Halterman JS, Auinger P, Conn KM, Lynch K, Yoos HL, Szilagyi PG. Inadequate therapy and poor symptom control among children with asthma: findings from a multistate sample. Ambul Pediatr. 2007 Mar-Apr;7(2):153-9. doi: 10.1016/j.ambp.2006.11.007.

    PMID: 17368410BACKGROUND
  • Okelo SO, Siberry GK, Solomon BS, Bilderback AL, Yamazaki M, Hetzler T, Ferrell CL, Dhepyasuwan N, Serwint JR; CORNET Investigators. Asthma treatment decisions by pediatric residents do not consistently conform to guidelines or improve with level of training. Acad Pediatr. 2014 May-Jun;14(3):287-93. doi: 10.1016/j.acap.2013.12.008. Epub 2014 Mar 12.

    PMID: 24629404BACKGROUND
  • National Heart Lung and Blood Institute. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. NIH Publication Number 08-5846. Bethesda, MD: 2007.

    BACKGROUND
  • Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007 Apr;119(4):817-25. doi: 10.1016/j.jaci.2006.12.662. Epub 2007 Mar 13.

    PMID: 17353040BACKGROUND
  • Schatz M, Zeiger RS, Drane A, Harden K, Cibildak A, Oosterman JE, Kosinski M. Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology. J Allergy Clin Immunol. 2007 Feb;119(2):336-43. doi: 10.1016/j.jaci.2006.08.042. Epub 2006 Dec 27.

    PMID: 17194469BACKGROUND
  • Halterman JS, Borrelli B, Fisher S, Szilagyi P, Yoos L. Improving care for urban children with asthma: design and methods of the School-Based Asthma Therapy (SBAT) trial. J Asthma. 2008 May;45(4):279-86. doi: 10.1080/02770900701854908.

    PMID: 18446591BACKGROUND
  • Halterman JS, Szilagyi PG, Fisher SG, Fagnano M, Tremblay P, Conn KM, Wang H, Borrelli B. Randomized controlled trial to improve care for urban children with asthma: results of the School-Based Asthma Therapy trial. Arch Pediatr Adolesc Med. 2011 Mar;165(3):262-8. doi: 10.1001/archpediatrics.2011.1.

    PMID: 21383275BACKGROUND
  • Halterman JS, Fagnano M, Montes G, Fisher S, Tremblay P, Tajon R, Sauer J, Butz A. The school-based preventive asthma care trial: results of a pilot study. J Pediatr. 2012 Dec;161(6):1109-15. doi: 10.1016/j.jpeds.2012.05.059. Epub 2012 Jul 10.

    PMID: 22785264BACKGROUND
  • Halterman JS, Fagnano M, Tajon RS, Tremblay P, Wang H, Butz A, Perry TT, McConnochie KM. Effect of the School-Based Telemedicine Enhanced Asthma Management (SB-TEAM) Program on Asthma Morbidity: A Randomized Clinical Trial. JAMA Pediatr. 2018 Mar 5;172(3):e174938. doi: 10.1001/jamapediatrics.2017.4938. Epub 2018 Mar 5.

    PMID: 29309483BACKGROUND
  • Halterman JS, Riekert KA, Fagnano M, Tremblay PJ, Blaakman SW, Tajon R, Wang H, Borrelli B. Effect of the School-Based Asthma Care for Teens (SB-ACT) program on asthma morbidity: a 3-arm randomized controlled trial. J Asthma. 2022 Mar;59(3):494-506. doi: 10.1080/02770903.2020.1856869. Epub 2021 Jan 8.

    PMID: 33307900BACKGROUND
  • Cain A, Reznik M. The Principal and Nurse Perspective on Gaps in Asthma Care and Barriers to Physical Activity in New York City Schools: A Qualitative Study. Health Educ Behav. 2018 Jun;45(3):410-422. doi: 10.1177/1090198117736351. Epub 2017 Oct 31.

    PMID: 29084455BACKGROUND
  • Reznik M, Bauman LJ, Okelo SO, Halterman JS. Asthma identification and medication administration forms in New York City schools. Ann Allergy Asthma Immunol. 2015 Jan;114(1):67-68.e1. doi: 10.1016/j.anai.2014.10.006. Epub 2014 Oct 24. No abstract available.

    PMID: 25454012BACKGROUND
  • Reznik M, Halterman JS. School asthma policies and teachers' confidence and attitudes about their role in asthma management. Ann Allergy Asthma Immunol. 2016 May;116(5):473-5. doi: 10.1016/j.anai.2016.03.005. Epub 2016 Mar 22. No abstract available.

    PMID: 27013055BACKGROUND
  • Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC); Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, Dixon AE, Elward KS, Hartert T, Krishnan JA, Lemanske RF Jr, Ouellette DR, Pace WD, Schatz M, Skolnik NS, Stout JW, Teach SJ, Umscheid CA, Walsh CG. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020 Dec;146(6):1217-1270. doi: 10.1016/j.jaci.2020.10.003.

    PMID: 33280709BACKGROUND
  • Hsia BC, Singh AK, Njeze O, Cosar E, Mowrey WB, Feldman J, Reznik M, Jariwala SP. Developing and evaluating ASTHMAXcel adventures: A novel gamified mobile application for pediatric patients with asthma. Ann Allergy Asthma Immunol. 2020 Nov;125(5):581-588. doi: 10.1016/j.anai.2020.07.018. Epub 2020 Jul 22.

    PMID: 32711031BACKGROUND
  • Hsia BC, Wu S, Mowrey WB, Jariwala SP. Evaluating the ASTHMAXcel Mobile Application Regarding Asthma Knowledge and Clinical Outcomes. Respir Care. 2020 Aug;65(8):1112-1119. doi: 10.4187/respcare.07550. Epub 2020 Jun 2.

    PMID: 32487751BACKGROUND
  • Halterman JS, Tajon R, Tremblay P, Fagnano M, Butz A, Perry TT, McConnochie KM. Development of School-Based Asthma Management Programs in Rochester, New York: Presented in Honor of Dr Robert Haggerty. Acad Pediatr. 2017 Aug;17(6):595-599. doi: 10.1016/j.acap.2017.04.008. Epub 2017 Apr 18.

    PMID: 28434913BACKGROUND
  • Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in the parents of children with asthma. Qual Life Res. 1996 Feb;5(1):27-34. doi: 10.1007/BF00435966.

    PMID: 8901364BACKGROUND
  • Taminskiene V, Alasevicius T, Valiulis A, Vaitkaitiene E, Stukas R, Hadjipanayis A, Turner S, Valiulis A. Quality of life of the family of children with asthma is not related to asthma severity. Eur J Pediatr. 2019 Mar;178(3):369-376. doi: 10.1007/s00431-018-3306-8. Epub 2019 Jan 4.

    PMID: 30607508BACKGROUND
  • Smith T, Mills K, Cober MP, Fenn NE 3rd, Hill C, King M, Pauley JL, Eiland L, Sierra C, Omecene NE. Updates in the treatment of asthma in pediatrics: A review for pharmacists. Am J Health Syst Pharm. 2024 Apr 19;81(9):e210-e219. doi: 10.1093/ajhp/zxad326.

    PMID: 38146826BACKGROUND
  • Hogan A, Kyler K, Seguin C. 2022. Get SMART: Implementation of Updated Asthma Guidelines for Pediatric Hospitalists.

    BACKGROUND
  • Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID. Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. Am J Respir Crit Care Med. 2019 Jun 15;199(12):1471-1477. doi: 10.1164/rccm.201810-1868CI.

    PMID: 30645143BACKGROUND
  • Bender B, Wamboldt FS, O'Connor SL, Rand C, Szefler S, Milgrom H, Wamboldt MZ. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol. 2000 Nov;85(5):416-21. doi: 10.1016/s1081-1206(10)62557-4.

    PMID: 11101187BACKGROUND
  • O'Connor SL, Bender BG, Gavin-Devitt LA, Wamboldt MZ, Milgrom H, Szefler S, Rand C, Wamboldt FS. Measuring adherence with the Doser CT in children with asthma. J Asthma. 2004 Sep;41(6):663-70. doi: 10.1081/jas-200026434.

    PMID: 15584316BACKGROUND
  • Mosnaim G, Li H, Martin M, Richardson D, Belice PJ, Avery E, Ryan N, Bender B, Powell L. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):485-93. doi: 10.1016/j.jaip.2013.06.010. Epub 2013 Aug 30.

    PMID: 24565620BACKGROUND
  • Makhecha S, Chan A, Pearce C, Jamalzadeh A, Fleming L. Novel electronic adherence monitoring devices in children with asthma: a mixed-methods study. BMJ Open Respir Res. 2020 Nov;7(1):e000589. doi: 10.1136/bmjresp-2020-000589.

    PMID: 33154086BACKGROUND
  • LaForce C, Albers FC, Cooper M, Danilewicz A, Dunsire L, Rees R, Cappelletti C. A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol-Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design. J Asthma Allergy. 2024 Aug 23;17:801-811. doi: 10.2147/JAA.S471134. eCollection 2024.

    PMID: 39193207BACKGROUND
  • Krings JG, Wojcik KM, Chen V, Sekhar TC, Harris K, Zulich A, Sumino K, Brownson R, Lenze E, Castro M. Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trial. Trials. 2022 Dec 5;23(1):975. doi: 10.1186/s13063-022-06916-3.

    PMID: 36471430BACKGROUND
  • Sun Y, Jariwala S, Reznik M. Measurement of adherence to inhaled corticosteroids by self-report and electronic medication monitoring. J Asthma. 2023 Jul;60(7):1299-1305. doi: 10.1080/02770903.2022.2144352. Epub 2022 Dec 1.

    PMID: 36343353BACKGROUND
  • Cohen JL, Mann DM, Wisnivesky JP, Home R, Leventhal H, Musumeci-Szabo TJ, Halm EA. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma. Ann Allergy Asthma Immunol. 2009 Oct;103(4):325-31. doi: 10.1016/s1081-1206(10)60532-7.

    PMID: 19852197BACKGROUND
  • Williams LK, Joseph CL, Peterson EL, Wells K, Wang M, Chowdhry VK, Walsh M, Campbell J, Rand CS, Apter AJ, Lanfear DE, Tunceli K, Pladevall M. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol. 2007 Nov;120(5):1153-9. doi: 10.1016/j.jaci.2007.08.020. Epub 2007 Oct 22.

    PMID: 17936894BACKGROUND
  • Apter AJ, Wan F, Reisine S, Bender B, Rand C, Bogen DK, Bennett IM, Bryant-Stephens T, Roy J, Gonzalez R, Priolo C, Have TT, Morales KH. The association of health literacy with adherence and outcomes in moderate-severe asthma. J Allergy Clin Immunol. 2013 Aug;132(2):321-7. doi: 10.1016/j.jaci.2013.02.014. Epub 2013 Apr 13.

    PMID: 23591273BACKGROUND
  • De Keyser HEH, Kaye L, Anderson WC, Gondalia R, Theye B, Szefler SJ, Stempel DA. Electronic medication monitors help determine adherence subgroups in asthma. Respir Med. 2020 Apr;164:105914. doi: 10.1016/j.rmed.2020.105914. Epub 2020 Feb 19.

    PMID: 32094102BACKGROUND
  • Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest. 2002 Mar;121(3):871-6. doi: 10.1378/chest.121.3.871.

    PMID: 11888975BACKGROUND
  • Loucks J, Zuckerman AD, Berni A, Saulles A, Thomas G, Alonzo A. Proportion of days covered as a measure of medication adherence. Am J Health Syst Pharm. 2022 Mar 7;79(6):492-496. doi: 10.1093/ajhp/zxab392. No abstract available.

    PMID: 34637496BACKGROUND
  • Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006 Jul;130(1 Suppl):65S-72S. doi: 10.1378/chest.130.1_suppl.65S.

    PMID: 16840369BACKGROUND
  • Reznik M, Silver EJ, Cao Y. Evaluation of MDI-spacer utilization and technique in caregivers of urban minority children with persistent asthma. J Asthma. 2014 Mar;51(2):149-54. doi: 10.3109/02770903.2013.854379. Epub 2013 Oct 22.

    PMID: 24131031BACKGROUND
  • Interiano B, Guntupalli KK. Metered-dose inhalers. Do health care providers know what to teach? Arch Intern Med. 1993 Jan 11;153(1):81-5. doi: 10.1001/archinte.153.1.81.

    PMID: 8422202BACKGROUND
  • Manzella BA, Brooks CM, Richards JM Jr, Windsor RA, Soong S, Bailey WC. Assessing the use of metered dose inhalers by adults with asthma. J Asthma. 1989;26(4):223-30. doi: 10.3109/02770908909073253.

    PMID: 2702229BACKGROUND
  • O'Connor KS, Osborn L, Olson L, Blumberg SJ, Frankel MR, Srinath KP, Giambo P. Design and operation of the National Asthma Survey. Vital Health Stat 1. 2008 Aug;(46):1-122.

    PMID: 18958992BACKGROUND
  • Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1-24.

    BACKGROUND
  • Horne R. Patients' beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res. 1999 Dec;47(6):491-5. doi: 10.1016/s0022-3999(99)00058-6. No abstract available.

    PMID: 10661596BACKGROUND
  • Sidora-Arcoleo K, Feldman J, Serebrisky D, Spray A. Validation of the Asthma Illness Representation Scale (AIRS). J Asthma. 2010 Feb;47(1):33-40. doi: 10.3109/02770900903362668.

    PMID: 20100018BACKGROUND
  • Sidora-Arcoleo KJ, Feldman J, Serebrisky D, Spray A. Validation of the Asthma Illness Representation Scale-Spanish (AIRS-S). J Asthma. 2010 May;47(4):417-21. doi: 10.3109/02770901003702832.

    PMID: 20528596BACKGROUND
  • Kan K, Fierstein J, Boon K, Madeleine Kanaley, Zavos P, Volerman A, Vojta D, Gupta RS. Parental quality of life and self-efficacy in pediatric asthma. J Asthma. 2021 Jun;58(6):742-749. doi: 10.1080/02770903.2020.1731825. Epub 2020 Feb 25.

    PMID: 32072838BACKGROUND
  • Bursch B, Schwankovsky L, Gilbert J, Zeiger R. Construction and validation of four childhood asthma self-management scales: parent barriers, child and parent self-efficacy, and parent belief in treatment efficacy. J Asthma. 1999;36(1):115-28. doi: 10.3109/02770909909065155.

    PMID: 10077141BACKGROUND
  • Fiese BH, Wamboldt FS, Anbar RD. Family asthma management routines: connections to medical adherence and quality of life. J Pediatr. 2005 Feb;146(2):171-6. doi: 10.1016/j.jpeds.2004.08.083.

    PMID: 15689901BACKGROUND
  • Clark NM, Gong M, Schork MA, Maiman LA, Evans D, Hurwitz ME, Roloff D, Mellins RB. A scale for Assessing Health Care Providers' Teaching and Communication Behavior regarding asthma. Health Educ Behav. 1997 Apr;24(2):245-56. doi: 10.1177/109019819702400211.

    PMID: 9079582BACKGROUND
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

    PMID: 11556941BACKGROUND
  • Matt GE, Wahlgren DR, Hovell MF, Zakarian JM, Bernert JT, Meltzer SB, Pirkle JL, Caudill S. Measuring environmental tobacco smoke exposure in infants and young children through urine cotinine and memory-based parental reports: empirical findings and discussion. Tob Control. 1999 Autumn;8(3):282-9. doi: 10.1136/tc.8.3.282.

    PMID: 10599573BACKGROUND
  • Holm, S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics. 1979; 6 (2): 65-70.

    BACKGROUND
  • Liang, K.Y. and Zeger, S. L. (1986), Longitudinal Data Analysis Using Generalized Linear Models. Biometrika, Vol. 73, No. 1., pp. 13-22.

    BACKGROUND
  • Rubin, D.B. Inference and missing data. Biometrika, 1976:63, 581-592.

    BACKGROUND
  • Imai K, Keele L, Tingley D. A general approach to causal mediation analysis. Psychol Methods. 2010 Dec;15(4):309-34. doi: 10.1037/a0020761.

    PMID: 20954780BACKGROUND

Study Officials

  • Marina Reznik, MD, MS

    Montefiore Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marina Reznik, MD, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Follow up assessments will be collected by blinded interviewers.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Cluster randomized design. Prior to participant enrollment, each practice will be matched into 9 pairs based on size of the practice and provider type. Practices will then be randomly selected within each pair to receive PRAGMATIC-S or remain as an Enhanced Usual Care (eUC) site. Practices will join study in 5 waves (2-4 practices per wave).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2025

First Posted

November 3, 2025

Study Start

February 12, 2026

Primary Completion (Estimated)

June 30, 2031

Study Completion (Estimated)

June 30, 2033

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

In addition to the research data, study protocols, data collection instruments, codebooks that contain variable names and format codes will be provided. Quantitative datasets will be in SPSS, STATA and/or SAS formats. All datasets that are shared will be accompanied by the relevant metadata. Scientific data will require either SAS, STATA or SPSS statistical software for manipulation. No other specialized tools will be needed to access or manipulate shared scientific data to support replication or reuse. To facilitate efficient use, all data and materials will be structured and described using the following standards: The majority of the longitudinal surveys use validated, standardized instruments. The SAS, STATA or SPSS codes used to score the measures and to prepare raw data for analyses will be provided. Medical record, hospitalization and ED data, electronic adherence monitor and data for all other measures will be organized and described according to best practices.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
In accordance with the NIH policy, de-identified and/or grouped dataset will be made available upon publication of related work or end of the project period, whichever comes first, and will remain available indefinitely.
Access Criteria
De-identified and/or grouped data from this project will accompany articles submitted to PubMed Central® (PMC) as supplementary materials. PubMed Central accepts data files (up to 2 GB) with manuscript submissions (via NIH Manuscript Submission System (NIHMS)) and ensures data is publicly accessible, persistent, and citable. The dataset will be linked to the published manuscript(s) in PubMed Central and assigned a persistent, citable digital object identifier (DOI).

Locations